747 Phase 1 trial of LYL845, an autologous tumor-infiltrating lymphocyte (TIL) therapy enhanced with epigenetic reprogramming, for the treatment of advanced solid tumors

747 Phase 1 trial of LYL845, an autologous tumor-infiltrating lymphocyte (TIL) therapy enhanced with epigenetic reprogramming, for the treatment of advanced solid tumors

Bibliographic Details
Main Authors:	Joal D Beane, Yazan Samhouri, Brent A Hanks, John Hyngstrom, Sarah Weiss, Heidi Gillenwater, Yeonhee Kim, J Randolph Hecht, Bishwa J Ganguly, Hajime Hiraragi, Lucy Gong, Navid Nikoo
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2023-11-01
Series:	Journal for ImmunoTherapy of Cancer

Similar Items

754 Phase 1 trial of LYL797, a ROR1-targeted CAR T-cell therapy enhanced with genetic and epigenetic reprogramming, in advanced triple-negative breast cancer (TNBC) and non-small cell lung cancer (NSCLC)
by: Haven Garber, et al.
Published: (2023-11-01)

50 números de LyL
by: Javier González Riffo
Published: (2024-10-01)

Boeing 747 /
by: Shaw, Robbie, author
Published: (1994)

Lyl-1 regulates primitive macrophages and microglia development
by: Shoutang Wang, et al.
Published: (2021-12-01)

Simulation of Hydraulic System Reliability 747
by: aliasghar tanha
Published: (2003-06-01)

21W.747 Rhetoric, Fall 2002
by: Strang, Steven M.
Published: (2002)

Cucumbers in Praxilla’s “Adonis” fragment (fr. 747)
by: P. A. Rosenmeyer
Published: (2022-12-01)

A 8.45 GHz GaAs FET amplifier
Published: (2004)

Ivan Denisovich (SCH-845) psychological survival code
by: Pergamenshchik L.A.
Published: (2013-07-01)

Requirement for Lyl1 in a model of Lmo2-driven early T-cell precursor ALL.
by: McCormack, M, et al.
Published: (2013)

21W.747-1 Rhetoric, Spring 2010
by: Strang, Steven
Published: (2010)

21W.747-1 Rhetoric, Spring 2006
by: Strang, Steven
Published: (2006)

21W.747-1 Rhetoric, Fall 2006
by: Strang, Steven
Published: (2006)

Handbook of small standardized components : master catalog 747
Published: (1979)

374~747 MHz digital tunable microstrip filter
by: Deng-yao TIAN, et al.
Published: (2016-08-01)

374~747 MHz digital tunable microstrip filter
by: Deng-yao TIAN, et al.
Published: (2016-08-01)

2, 845 graduan UMP bakal terima diploma, ijazah
by: UMP, PNC
Published: (2017)

Expansion of tumor-infiltrating lymphocytes (TIL) from human pancreatic tumors
by: Hao Liu, et al.
Published: (2016-11-01)

Functional circuits of LYL1 controlled by supraphysiological androgen in prostate cancer cells to regulate cell senescence
by: Mehdi Heidari Horestani, et al.
Published: (2024-12-01)

Characterization of a pediatric T-cell acute lymphoblastic leukemia patient with simultaneous LYL1 and LMO2 rearrangements
by: Irene Homminga, et al.
Published: (2012-02-01)

Lyl1-deficiency promotes inflammatory responses and increases mycobacterial burden in response to Mycobacterium tuberculosis infection in mice
by: Shelby-Sara Jones, et al.
Published: (2022-09-01)

Angiopoietin-2 is a direct transcriptional target of TAL1, LYL1 and LMO2 in endothelial cells.
by: Virginie Deleuze, et al.
Published: (2012-01-01)

CCNP optimizing converged networks (ONT 642-845) lab portfolio /
by: 188479 Kotfila, David A., et al.
Published: (2008)

Leading causes of cardiovascular hospitalization in 8.45 million US veterans.
by: Nirupama Krishnamurthi, et al.
Published: (2018-01-01)

Tumor-infiltrating lymphocytes (TILs) from patients with glioma
by: Zhenjiang Liu, et al.
Published: (2017-02-01)

278 Preclinical development of LYL119, a ROR1-targeted CAR T-cell product incorporating four novel T-cell reprogramming technologies to overcome barriers to effective cell therapy for solid tumors
by: Rachel C Lynn, et al.
Published: (2023-11-01)

LYL1 degradation by the proteasome is directed by a N-terminal PEST rich site in a phosphorylation-independent manner.
by: Georgi L Lukov, et al.
Published: (2010-09-01)

Correction: Leading causes of cardiovascular hospitalization in 8.45 million US veterans.
by: Nirupama Krishnamurthi, et al.
Published: (2018-01-01)

21W.747-3 Classical Rhetoric and Modern Politics, Spring 2006
by: Perelman, Leslie
Published: (2006)

Expansion of tumor infiltrating lymphocytes (TIL) from bladder cancer
by: Michael Poch, et al.
Published: (2018-09-01)

Expansion and characterization of human melanoma tumor-infiltrating lymphocytes (TILs).
by: Linh T Nguyen, et al.
Published: (2010-11-01)

Prognostic Significance of the Lymphoblastic Leukemia-Derived Sequence 1 (LYL1) Gene Expression in Egyptian Patients with Acute Myeloid Leukemia
by: Nadia El Menshawy, et al.
Published: (2014-05-01)

Super-enhancer profiling identifies novel critical and targetable cancer survival gene LYL1 in pediatric acute myeloid leukemia
by: Fang Fang, et al.
Published: (2022-07-01)

Dido en Pompeyo (Phars., VIII, 843-845): motivaciones de la intertextualidad
by: Ana Clara Sisul
Published: (2014-11-01)

Review of clinical non-medico-legal autopsy: a descriptive study in 747 patients
by: Oscar Mendoza, et al.
Published: (2018-11-01)

LYL1 gene amplification predicts poor survival of patients with uterine corpus endometrial carcinoma: analysis of the Cancer genome atlas data
by: Se Ik Kim, et al.
Published: (2018-05-01)

Analysis of the lymphoid tumor microenvironment (TILs) in breast cancer by flow cytometry
by: T. N. Zabotina, et al.
Published: (2024-07-01)

393 Rejuvenation of tumor-infiltrating lymphocytes (TIL) through partial reprogramming
by: Biao Wang, et al.
Published: (2023-11-01)

Synthetic TILs: Engineered Tumor-Infiltrating Lymphocytes With Improved Therapeutic Potential
by: Anaïs Jiménez-Reinoso, et al.
Published: (2021-02-01)

665 Transcriptional landscape of tumor-reactive TIL in lung cancer and melanoma
by: Jiajia Zhang, et al.
Published: (2021-11-01)